As part of the deal, stemming from fatal 737 Max crashes in 2018 and 2019, the company agreed to pay a fine of nearly half a billion dollars and strengthen its safety programs.
Category: Factories and Manufacturing
U.S. Said to Seek Boeing Guilty Plea to Avoid Trial in 737 Max Crashes
The Justice Department told victims’ families that it would propose a nearly $244 million fine and three years of company oversight to settle a fraud charge.
Boeing Sanctioned by NTSB Over Disclosures on 737 Max Investigation
The National Transportation Safety Board said Boeing had improperly released information about the blowout of a panel on an Alaska Airlines flight.
A Big Decision for Boeing’s Next C.E.O.: Is It Time for a New Plane?
Some analysts say building a new plane soon would help the company regain ground it has lost to Airbus. But doing so would be difficult and expensive.
The Floating Traffic Jam That Freaked Us All Out
The coronavirus pandemic schooled the world in the essential role of global supply chains. Have we learned anything from it?
Biden’s China Tariffs Are the End of an Era for Cheap Chinese Goods
The president’s move to protect strategic manufacturing sectors from low-cost competition aims to increase jobs, but consumers might not like the costs.
UAW Loses Unionization Vote at Mercedes Factories in Alabama
The election, fiercely opposed by the state’s political leaders, was seen as a test of the United Automobile Workers’ ability to unionize factories in the South.
Few Chinese Electric Cars Are Sold in U.S., but Industry Fears a Flood
Automakers in the United States and their supporters welcomed President Biden’s tariffs, saying they would protect domestic manufacturing and jobs from cheap Chinese vehicles.
‘It Is Desolate’: China’s Glut of Unused Car Factories
Manufacturers like BYD, Tesla and Li Auto are cutting prices to move their electric cars. For gasoline-powered vehicles, the surplus of factories is even worse.
Inside Novo Nordisk, the Company Behind Ozempic and Wegovy
Novo Nordisk’s factories work nonstop turning out Ozempic and Wegovy, its blockbuster weight-loss drugs, but the Danish company has far bigger ambitions.